The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma
Open accessAbstract
Background & aims Despite the significant association between obesity and several cancers, it has been difficult to establish an association between obesity and hepatocellular carcinoma (HCC). Patients with HCC often have ascites, making it a challenge to determine body mass index (BMI) accurately, and many factors contribute to the development of HCC. We performed a case-control study to investigate whether obesity early in adulthood affects risk, age of onset, or outcomes of patients with HCC.Methods We interviewed 622 patients newly diagnosed with HCC from January 2004 through December 2013, along with 660 healthy controls (frequency-matched by age and sex) to determine weights, heights, and body sizes (self-reported) at various ages before HCC development or enrollment as controls. Multivariable logistic and Cox regression analyses were performed to determine the independent effects of early obesity on risk for HCC and patient outcomes, respectively. BMI was calculated, and patients with a BMI of 30 kg/m(2) or greater were considered obese.Results Obesity in early adulthood (age, mid-20s to mid-40s) is a significant risk factor for HCC. The estimated odds ratios were 2.6 (95% confidence interval [CI], 1.4-4.4), 2.3 (95% CI, 1.2-4.4), and 3.6 (95% CI, 1.5-8.9) for the entire population, for men, and for women, respectively. Each unit increase in BMI at early adulthood was associated with a 3.89-month decrease in age at HCC diagnosis (P < .001). Moreover, there was a synergistic interaction between obesity and hepatitis virus infection. However, we found no effect of obesity on the overall survival of patients with HCC.Conclusions Early adulthood obesity is associated with an increased risk of developing HCC at a young age in the absence of major HCC risk factors, with no effect on outcomes of patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The early onset of obesity has a meaningful impact on the development of HCC, as shown in a case-control study comparing 622 individuals with newly diagnosed HCC and 660 healthy controls, where obesity in early adulthood was associated with HCC development.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Llovet, J. M., Burroughs, A. K., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,637
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,695
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,102
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C. N., Furuse, J., & de Guevara, L. L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 966
Effects of Age on Validity of Self-Reported Height, Weight, and Body Mass Index
KUCZMARSKI, M. F., KUCZMARSKI, R. J., & NAJJAR, M. (2001) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(01)00008-6 · Cited by 965
Molecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3174 · Cited by 921
ROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859
El‐Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 831
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 672
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 548
Hepatocellular carcinoma epidemiology
Bosetti, C., Turati, F., & Vecchia, C. L. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 543
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 501
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer
Li, D. (2009) · JAMA · doi:10.1001/jama.2009.886 · Cited by 474
Self-report and medical record report agreement of selected medical conditions in the elderly.
Bush, T. L., Miller, S. R., Golden, A. L., & Hale, W. E. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.11.1554 · Cited by 465
ACCURACY OF CURRENT, 4-YEAR, AND 28-YEAR SELF-REPORTED BODY WEIGHT IN AN ELDERLY POPULATION
Stevens, J., KEIL, J. E., Waid, L. R., & Gazes, P. C. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115758 · Cited by 357
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors
Meyer, M. R., Clegg, D. J., Prossnitz, E. R., & Barton, M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02237.x · Cited by 338
THE ESTIMATION OF SYNERGY OR ANTAGONISM1
Rothman, K. J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112252 · Cited by 335
Simpson, C. F., Boyd, C. M., Carlson, M. C., Griswold, M. E., Guralnik, J. M., & Fried, L. P. (2003) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52021.x · Cited by 332
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S. M., Zeuzem, S., Davila, J. A., El‐Serag, H. B., & McGlynn, K. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 326
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
Hassan, M. M., Curley, S. A., Li, D., Kaseb, A. O., Davila, M. L., Abdalla, E. K., Javle, M. M., Moghazy, D. M., Lozano, R. D., Abbruzzese, J. L., et al. (2010) · Cancer · doi:10.1002/cncr.24982 · Cited by 308
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
Haluzı́k, M., Pařízková, J., & Haluzík, M. (2004) · Physiological Research · doi:10.33549/physiolres.930479 · Cited by 247
Host- and disease-specific factors affecting steatosis in chronic hepatitis C
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80004-4 · Cited by 246
Loomba, R., Yang, H.-I., Su, J., Brenner, D., Barrett-Connor, E., Iloeje, U., & Chen, C.-J. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws252 · Cited by 221
Long-term memory of body weight and past weight satisfaction: a longitudinal follow-up study
Casey, V., Dwyer, J. T., Berkey, C. S., Coleman, K. A., Gardner, J., & Valadian, I. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1493 · Cited by 199
Tateishi, R., Okanoue, T., Fujiwara, N., Okita, K., Kiyosawa, K., Omata, M., Kumada, H., Hayashi, N., & Koike, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0973-8 · Cited by 170
Alhyas, L. A., McKay, A. J., Balasanthiran, A., & Majeed, A. (2011) · JRSM Short Reports · doi:10.1258/shorts.2011.011019 · Cited by 167
Gunnell, D., Berney, L., Holland, P., Maynard, M., Blane, D., Frankel, S., & Smith, G. D. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.3.456 · Cited by 167
Ohki, T., Tateishi, R., Sato, T., Masuzaki, R., Imamura, J., Goto, T., Yamashiki, N., Yoshida, H., Kanai, F., Kato, N., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.012 · Cited by 159
Kaseb, A. O., Morris, J. S., Hassan, M. M., Siddiqui, A. M., Lin, E., Xiao, L., Abdalla, E. K., Vauthey, J., Aloia, T. A., Krishnan, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0636 · Cited by 129
SAUNDERS, D., SEIDEL, D., Allison, M., & Lyratzopoulos, G. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04271.x · Cited by 114
Body Mass Index and Adverse Perioperative Outcomes Following Hepatic Resection
Mathur, A. K., Ghaferi, A. A., Osborne, N. H., Pawlik, T. M., Campbell, D. A., Englesbe, M. J., & Welling, T. H. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1232-9 · Cited by 109
Hassan, M. M., Spitz, M. R., Thomas, M. B., Curley, S. A., Patt, Y. Z., Vauthey, J., Glover, K. Y., Kaseb, A. O., Lozano, R. D., El‐Deeb, A. S., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.016 · Cited by 89
Dynamics of insulin secretion in obesity and diabetes
Polonsky, K. S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801273 · Cited by 86
Hassan, M. M., Kaseb, A. O., Etzel, C. J., El‐Serag, H. B., Spitz, M. R., Chang, P., Stemke‐Hale, K., Liu, M., Rashid, A., Shama, M., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22057 · Cited by 85
Hassan, M. M., Spitz, M. R., Thomas, M. B., El‐Deeb, A. S., Glover, K. Y., Nguyen, N. T., Chan, W., Kaseb, A. O., Curley, S. A., Vauthey, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23730 · Cited by 85
Xu, L., Han, C. L., Lim, K., & Wu, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1445 · Cited by 84
Alcohol Consumption, Folate Intake, Hepatocellular Carcinoma, and Liver Disease Mortality
Persson, E. C., Schwartz, L. M., Park, Y., Trabert, B. L., Hollenbeck, A. R., Graubard, B. I., Freedman, N. D., & McGlynn, K. A. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1169 · Cited by 84
Viral Hepatitis and Hepatocellular Carcinoma
Marrero, C. R., & Marrero, J. A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.09.004 · Cited by 83
Safety of Liver Resections in Obese and Overweight Patients
Balzan, S. M. P., Nagarajan, G., Farges, O., Galleano, C. Z., Dokmak, S., Paugam‐Burtz, C., & Belghiti, J. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0756-1 · Cited by 78
Obesity, adipokines and hepatocellular carcinoma
Duan, X.-F., Tang, P., Li, Q., & Yu, Z. (2013) · International Journal of Cancer · doi:10.1002/ijc.28105 · Cited by 75
Interaction between hepatitis C virus and metabolic factors
Kawaguchi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i11.2888 · Cited by 69
Alcohol, cofactors and the genetics of hepatocellular carcinoma
Yu, M. C., Yuan, J., & Lu, S. C.-L. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05293.x · Cited by 63
Leptin in hepatocellular carcinoma
Wang, S.-N. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i46.5801 · Cited by 59
Study, F. T. H. A., Houston, D. K., Ding, J., Nicklas, B. J., Harris, T. B., Lee, J. S., Nevitt, M. C., Rubin, S. M., Tylavsky, F. A., & Kritchevsky, S. B. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803652 · Cited by 59
Utsunomiya, T. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1553 · Cited by 57
Accuracy of Patients' Reports of Comorbid Disease and Their Association With Mortality in ESRD
Cavanaugh, K. L., Merkin, S. S., Plantinga, L., Fink, N. E., Sadler, J. H., & Powe, N. R. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.001 · Cited by 45
Systemic Therapy for Hepatocellular Carcinoma
Thomas, M. B. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31816a6058 · Cited by 41
Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update
Ramírez, A. G., Muñoz, E., Holden, A. E. C., Adeigbe, R. T., & Suarez, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099365 · Cited by 34
Wada, R., Koyama, M., Mizukami, H., Odaka, H., Ikeda, H., & Yagihashi, S. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5 · Cited by 29
Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma
Shin, E., Yu, Y., Kim, D., & Won, N. H. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9747-0 · Cited by 29
Obesity and Microvascular Invasion in Hepatocellular Carcinoma
Siegel, A. B., Wang, S., Jacobson, J. S., Hershman, D. L., Lim, E. A., Yu, J. C., Ferrante, L. E., Devaraj, K. M., Remotti, H. E., Scrudato, S., et al. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.483500 · Cited by 28
Kaseb, A. O., Xiao, L., Hassan, M. M., Chae, Y. K., Lee, J., Vauthey, J., Krishnan, S., Cheung, S. H., Hassabo, H. M., Aloia, T. A., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju088 · Cited by 28
Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis
Tanaka, S., Iimuro, Y., Hirano, T., Hai, S., Suzumura, K., Nakamura, I., Kondo, Y., & Fujimoto, J. (2013) · Surgery Today · doi:10.1007/s00595-013-0706-2 · Cited by 26
Sohda, T., KAMIMURA, S., Iwata, K., Shijo, H., & Okumura, M. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00412.x · Cited by 17
Connecting the dots: obesity, fatty acids and cancer
Wood, P. A. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.99 · Cited by 12
Correction: Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update
Staff, T. P. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103693 · Cited by 9
Obesity, Fatty Liver and Liver Cancer
Yu, J. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-8684-7 · Cited by 8
Cited by
Sorted by citations
Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2020) · Hepatology · doi:10.1002/hep.31288 · Cited by 2,200
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
Metadata
- Authors
- Hassan, M. M., Abdel-Wahab, R., Kaseb, A., Shalaby, A., Phan, A. T., El-Serag, H. B., Hawk, E., Morris, J., Singh Raghav, K. P., Lee, J.-S., Vauthey, J.-N., Bortus, G., Torres, H. A., Amos, C. I., Wolff, R. A., & Li, D.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Houston Methodist (US)
- Dartmouth College (US)
- Corresponding author
- Hassan, Manal M.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 149
- Issue
- 1
- Pages
- 119-129
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC4778392
- OpenAlex
- W2052145855
- Cited by
- 110
- References
- 66
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 6 · 2021: 9 · 2020: 15 · 2019: 7 · 2018: 15 · 2017: 11 · 2016: 11 · 2015: 8
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA106458-01, K07CA106458, P30CA023108, P30CA016672)
- National Institute of Environmental Health Sciences (R03ES11481, R03ES011481)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- hepatocellular carcinoma, obesity, early adulthood, body mass index, cancer risk, age at diagnosis, hepatitis virus infection, overall survival, sex differences
- MeSH terms
- Adult, Aged, Aging, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Obesity, Risk Factors, Body Mass Index, Case-Control Studies, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
